Creative Financial Designs’s Takeda Pharmaceutical TAK Stock Holding History

Creative Financial Designs’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.58K	Hold	535	–	–	﹤0.01%	1554
2026 Q1	$9.91K	Sell	535 -669	-56%	-$11.7K	﹤0.01%	1413
2025 Q4	$18.8K	Sell	1,204 -14	-1%	-$200	﹤0.01%	1168
2025 Q3	$17.8K	Buy	1,218 +284	+30%	+$4.22K	﹤0.01%	1179
2025 Q2	$14.4K	Buy	934 +521	+126%	+$7.7K	﹤0.01%	1229
2025 Q1	$6.14K	Buy	413 +148	+56%	+$2.07K	﹤0.01%	1431
2024 Q4	$3.51K	Hold	265	–	–	﹤0.01%	1491
2024 Q3	$3.77K	Hold	265	–	–	﹤0.01%	1438
2024 Q2	$3.43K	Buy	+265	New	+$3.51K	﹤0.01%	1398
2021 Q1	–	Sell	-35	Closed	-$1K	–	1359
2020 Q4	$1K	Hold	35	–	–	﹤0.01%	1206
2020 Q3	$1K	Hold	35	–	–	﹤0.01%	1181
2020 Q2	$1K	Buy	+35	New	+$628	﹤0.01%	1127

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Creative Financial Designs's TAK Position: Q2 2026 in Review

Creative Financial Designs held its Takeda Pharmaceutical (TAK) position steady in Q2 2026 at 535 shares worth $8.58K. The position accounts for ﹤0.01% of the portfolio, ranked #1554.

Creative Financial Designs first reported a position in TAK in Q2 2020 and has held it in 12 quarters since. The position peaked at $18.8K in Q4 2025. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

Creative Financial Designs held 535 shares of Takeda Pharmaceutical worth $8.58K as of Q2 2026.
Creative Financial Designs left its Takeda Pharmaceutical share count unchanged in Q2 2026.
Takeda Pharmaceutical made up ﹤0.01% of Creative Financial Designs's portfolio in Q2 2026, its #1554 holding.
Creative Financial Designs first reported a position in Takeda Pharmaceutical in Q2 2020 and has held it in 12 quarters since.
Creative Financial Designs's Takeda Pharmaceutical position peaked at $18.8K in Q4 2025.
376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Creative Financial Designs's 13F filing for Q2 2026, filed 28 Jul 2026.